Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.
Mild traumatic brain injury (mTBI) patients may have trauma-induced brain lesions detectable using CT scans. However, most patients will be CT-negative. There is thus a need for an additional tool to detect patients at risk. Single blood biomarkers, such as S100B and GFAP, have been widely studied i...
Main Authors: | Linnéa Lagerstedt, Juan José Egea-Guerrero, Alejandro Bustamante, Ana Rodríguez-Rodríguez, Amir El Rahal, Manuel Quintana-Diaz, Roser García-Armengol, Carmen Melinda Prica, Elisabeth Andereggen, Lara Rinaldi, Asita Sarrafzadeh, Karl Schaller, Joan Montaner, Jean-Charles Sanchez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6037378?pdf=render |
Similar Items
-
H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.
by: Linnéa Lagerstedt, et al.
Published: (2017-01-01) -
Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury.
by: Linnéa Lagerstedt, et al.
Published: (2018-01-01) -
Monitoring in neurointensive care – The challenge to detect delayed cerebral ischemia in high grade aneurysmal SAH
by: Asita S Sarrafzadeh, et al.
Published: (2014-07-01) -
High expression of FABP4 and FABP6 in patients with colorectal cancer
by: Yaqin Zhang, et al.
Published: (2019-10-01) -
Is continuous insulin treatment safe in aneurysmal subarachnoid hemorrhage?
by: Florian Schlenk, et al.
Published: (2008-08-01)